The end of the Mosaico vaccine trial must be a spur to deliver HIV treatment and prevention options to all who need them says UNAIDS
The end of the Mosaico HIV vaccine trial must lead to a continued drive to innovate as well as an urgency to ensure that proven HIV prevention and treatment options reach all who need them, says UNAIDS. Rapid progress against the HIV pandemic is possible if existing prevention and treatment options are made available through the sharing of technologies, expanding provision,
Source: unaids.org